Britta Wahrén

17.7k total citations
491 papers, 13.7k citations indexed

About

Britta Wahrén is a scholar working on Virology, Epidemiology and Immunology. According to data from OpenAlex, Britta Wahrén has authored 491 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 214 papers in Virology, 179 papers in Epidemiology and 171 papers in Immunology. Recurrent topics in Britta Wahrén's work include HIV Research and Treatment (210 papers), Cytomegalovirus and herpesvirus research (100 papers) and Immune Cell Function and Interaction (80 papers). Britta Wahrén is often cited by papers focused on HIV Research and Treatment (210 papers), Cytomegalovirus and herpesvirus research (100 papers) and Immune Cell Function and Interaction (80 papers). Britta Wahrén collaborates with scholars based in Sweden, United States and Italy. Britta Wahrén's co-authors include Jorma Hinkula, Annika Linde, Margaret A. Liu, V A Sundqvist, Eric Sandström, Ulla Rudén, Olle Ringdén, Maria Brytting, Johan Harmenberg and Göran Bratt and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Britta Wahrén

485 papers receiving 12.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Britta Wahrén Sweden	56	5.4k	4.5k	4.4k	3.3k	3.1k	491	13.7k
John Ghrayeb United States	36	2.9k 0.5×	4.7k 1.1×	4.5k 1.0×	2.2k 0.7×	2.4k 0.8×	58	11.2k
Scott Koenig United States	55	3.4k 0.6×	5.9k 1.3×	6.1k 1.4×	4.0k 1.2×	2.8k 0.9×	102	13.6k
Paolo Lusso United States	56	4.8k 0.9×	5.2k 1.2×	6.1k 1.4×	3.4k 1.0×	1.9k 0.6×	198	12.5k
Gene M. Shearer United States	52	3.1k 0.6×	7.3k 1.6×	5.9k 1.3×	3.0k 0.9×	2.1k 0.7×	197	13.3k
Peter C. L. Beverley United Kingdom	71	3.3k 0.6×	11.8k 2.6×	3.6k 0.8×	2.5k 0.8×	3.8k 1.2×	297	19.0k
Benhur Lee United States	63	4.4k 0.8×	5.3k 1.2×	4.3k 1.0×	4.1k 1.2×	3.3k 1.1×	202	13.1k
S Broder United States	46	2.0k 0.4×	3.4k 0.7×	4.1k 0.9×	4.7k 1.4×	2.7k 0.9×	96	10.8k
Paul R. Clapham United Kingdom	53	2.7k 0.5×	7.8k 1.7×	10.2k 2.3×	4.7k 1.4×	2.7k 0.9×	127	14.4k
Rafick‐Pierre Sékaly United States	70	3.5k 0.6×	12.1k 2.7×	8.8k 2.0×	4.6k 1.4×	3.4k 1.1×	310	19.1k
Dani P. Bolognesi United States	53	3.0k 0.6×	4.3k 1.0×	7.5k 1.7×	5.3k 1.6×	4.0k 1.3×	175	13.5k

Countries citing papers authored by Britta Wahrén

Since Specialization

Citations

This map shows the geographic impact of Britta Wahrén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britta Wahrén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britta Wahrén more than expected).

Fields of papers citing papers by Britta Wahrén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Britta Wahrén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britta Wahrén. The network helps show where Britta Wahrén may publish in the future.

Co-authorship network of co-authors of Britta Wahrén

This figure shows the co-authorship network connecting the top 25 collaborators of Britta Wahrén. A scholar is included among the top collaborators of Britta Wahrén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britta Wahrén. Britta Wahrén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Joachim, Agricola, Sayali Onkar, Patricia Munseri, et al.. (2020). Frequent and Durable Anti-HIV Envelope VIV2 IgG Responses Induced by HIV-1 DNA Priming and HIV-MVA Boosting in Healthy Tanzanian Volunteers. Vaccines. 8(4). 681–681. 4 indexed citations

Nilsson, Charlotta, Bindiya Meggi, Orvalho Augusto, et al.. (2017). Intradermal HIV-1 DNA Immunization Using Needle-Free Zetajet Injection Followed by HIV-Modified Vaccinia Virus Ankara Vaccination Is Safe and Immunogenic in Mozambican Young Adults: A Phase I Randomized Controlled Trial. AIDS Research and Human Retroviruses. 34(2). 193–205. 14 indexed citations

Joachim, Agricola, Patricia Munseri, Charlotta Nilsson, et al.. (2016). Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers. AIDS Research and Human Retroviruses. 33(8). 880–888. 15 indexed citations

Nilsson, Charlotta, Karina Godoy‐Ramirez, Bo Hejdeman, et al.. (2013). Broad and Potent Cellular and Humoral Immune Responses After a Second Late HIV-Modified Vaccinia Virus Ankara Vaccination in HIV-DNA-Primed and HIV-Modified Vaccinia Virus Ankara-Boosted Swedish Vaccinees. AIDS Research and Human Retroviruses. 30(3). 299–311. 23 indexed citations

Hejdeman, Bo, Sandra A. Calarota, Rodiça Lenkei, et al.. (2004). DNA Immunization with HIV Early Genes in HIV Type 1-Infected Patients on Highly Active Antiretroviral Therapy. AIDS Research and Human Retroviruses. 20(8). 860–870. 23 indexed citations

Isaguliants, Maria, Sergey Belikov, Elizaveta Starodubova, et al.. (2004). Mutations Conferring Drug Resistance Affect Eukaryotic Expression of HIV Type 1 Reverse Transcriptase. AIDS Research and Human Retroviruses. 20(2). 191–201. 15 indexed citations

Eriksson, Lars E., Kerstin I. Falk, Göran Bratt, et al.. (2003). HIV Type 1 DNA Development during Long-Term Supervised Therapy Interruption. AIDS Research and Human Retroviruses. 19(4). 259–265. 3 indexed citations

Ljungberg, Karl, et al.. (2002). Subtypes A, C, G, and Recombinant HIV Type 1 Are Circulating in Bangladesh. AIDS Research and Human Retroviruses. 18(9). 667–670. 15 indexed citations

Hejdeman, Bo, et al.. (2001). Clinical and Immunological Benefits from Highly Active Antiretroviral Therapy in Spite of Limited Viral Load Reduction in HIV Type 1 Infection. AIDS Research and Human Retroviruses. 17(4). 277–286. 24 indexed citations

10.

Zuber, Bartek, D Böttiger, Reinhold Benthin, et al.. (2001). An in Vivo Model for HIV Resistance Development. AIDS Research and Human Retroviruses. 17(7). 631–635. 18 indexed citations

11.

Hinkula, Jorma, et al.. (2000). A Retro-Inverso Miniantibody with Anti-HIV Activity. AIDS Research and Human Retroviruses. 16(1). 59–65. 11 indexed citations

12.

Isaguliants, Maria, Severin O. Gudima, Michael Levi, et al.. (2000). Immunogenic Properties of Reverse Transcriptase of HIV Type 1 Assessed by DNA and Protein Immunization of Rabbits. AIDS Research and Human Retroviruses. 16(13). 1269–1280. 13 indexed citations

13.

Duarte, Carlos A., Marinieve Montero, Rodolfo Valdés, et al.. (1994). Multiepitope Polypeptide of the HIV-1 Envelope Induces Neutralizing Monoclonal Antibodies against V3 Loop. AIDS Research and Human Retroviruses. 10(3). 235–243. 39 indexed citations

14.

Lolli, Francesco, et al.. (1994). HIV Antigen-Reactive T Cells Detected by Antigen-Induced Interferon γ Secretion. AIDS Research and Human Retroviruses. 10(2). 115–120. 10 indexed citations

15.

Isaguliants, Maria, et al.. (1994). Linear Epitopes of HIV-1, Presented as Hybrids with Escherichia Coli β-Galactosidase or Synthetic Peptides. AIDS Research and Human Retroviruses. 10(6). 655–664. 2 indexed citations

16.

Cox, S. W., et al.. (1994). Comparison of the Sensitivities of Primary Isolates of HIV Type 2 and HIV Type 1 to Antiviral Drugs and Drug Combinations. AIDS Research and Human Retroviruses. 10(12). 1725–1729. 29 indexed citations

17.

Cox, S. W., Jan Albert, Johan Wahlberg, Mathias Uhlén, & Britta Wahrén. (1992). Loss of Synergistic Response to Combinations Containing AZT in AZT-Resistant HIV-1. AIDS Research and Human Retroviruses. 8(7). 1229–1234. 17 indexed citations

18.

Niedrig, Matthias, Hans-Peter Harthus, Jorma Hinkula, et al.. (1992). Inhibition of viral replication by monoclonal antibodies directed against human immunodeficiency virus gp120. Journal of General Virology. 73(9). 2451–2455. 14 indexed citations

19.

Duarte, Carlos A., Jorma Hinkula, Per-Anders Broliden, et al.. (1991). Monoclonal Antibodies to Conserved Regions of the Major Core Protein ( gag 24) of HIV-1 and HIV-2. AIDS Research and Human Retroviruses. 7(1). 97–101. 10 indexed citations

20.

Mathiesen, Tiit, Annika Linde, Elisabeth Olding-Stenkvist, & Britta Wahrén. (1988). Specific IgG subclass reactivity in herpes simplex encephalitis. Journal of Neurology. 235(7). 400–406. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact